TNFSF11 and neoplasm: In turn, tumor cells enhance osteoclast activity through several mechanisms, including the direct secretion of RANKL, the upregulation of RANKL in osteoblasts and stromal cells, RANKL-independent pathways, and the suppression of osteoprotegerin [201].